Shanghai SunBio Showcases at 2025 ADLM, Advancing Global Market Expansion

From July 27-31, 2025, the 77th Annual Scientific Meeting & Clinical Lab Expo (ADLM) took place in Chicago, drawing over 20,000 clinical laboratory professionals from 110 countries worldwide. As the premier global event for clinical diagnostics, ADLM provided the perfect platform for Shanghai SunBio to demonstrate its groundbreaking coagulation diagnostic innovations to the international medical community.

UG2500 Optical-Magnetic Aggregation Coagulation Analyzer

Shanghai SunBio's UG2500 fully automated coagulation analyzer emerged as a standout attraction at ADLM 2025. UG2500 seamlessly integrates optical detection, mechanical methods, and platelet aggregation technologies—once again earned acclaim from global laboratory experts at this prestigious international forum.

The UG2500 delivers comprehensive testing capabilities for both primary and secondary hemostasis. Its innovative optical-magnetic detection technology effectively eliminates common analytical interferences from hemolysis, lipemia, and icterus, ensuring exceptional precision and reliability. This versatility makes it an ideal solution for diverse clinical laboratory environments worldwide.

Advanced Product Portfolio Demonstrates Manufacturing Excellence

During the exhibition, Shanghai SunBio presented its complete range of high-throughput coagulation analyzers engineered for large-scale medical laboratories. The UR6000 and UR8000 systems attracted significant international attention for their consistent performance and superior efficiency. The UR8000, recognized as the world's highest throghput coagulation analyzer, exemplifies Sunbio leadership in advanced medical equipment manufacturing. The UL-2000LAS laboratory automation system impressed visitors with its intelligent design, exceptional efficiency, and precise testing capabilities—delivering a comprehensive automation solution for modern healthcare institutions.

These cutting-edge platforms not only showcase the innovation and precision engineering capabilities within China's medical device sector but also demonstrate that Sunbio diagnostic technology has achieved world-class standards. They represent truly competitive solutions for the global clinical testing market.

ADLM 2025 served as a strategic platform for Shanghai SunBio to showcase its comprehensive product portfolio and technical expertise, highlighting the company's innovation capabilities on the world stage. This participation marks a significant milestone in the company's international expansion journey, reinforcing the growing global presence of Chinese medical device enterprises and their technological competitiveness.

Moving forward, Shanghai SunBio remains committed to its mission of "Creating Products for Life," continuing to deliver precise and reliable coagulation testing solutions to healthcare institutions worldwide while contributing to the advancement of the global clinical diagnostics industry.